Collaborative Projects to Accelerate Research in Organ Fibrosis (R01)

The summary for the Collaborative Projects to Accelerate Research in Organ Fibrosis (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Collaborative Projects to Accelerate Research in Organ Fibrosis (R01): While fibrogenesis is an essential process in normal wound healing, aberrant and relentless fibrogenesis in vital organs such as heart, lung, kidney, and bone marrow can lead to debilitating symptoms and organ failure. Aberrant fibrogenesis at the cellular level shows remarkable similarities across different organ systems. Moreover, a disease such as systemic sclerosis or an injury such as ionizing radiation may cause fibrosis in more than one organ system. Thus, collaborations among researchers studying fibrosis in different organ systems may greatly accelerate research in this area. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications from collaborating investigators to characterize and compare mechanisms of aberrant fibrogenesis and/or fibrosis resolution in different organ systems; develop novel therapeutic strategies aimed to lessen organ fibrosis; or develop novel technologies to study fibrosis.

Federal Grant Title:	Collaborative Projects to Accelerate Research in Organ Fibrosis (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-16-003
Type of Funding:	Grant
CFDA Numbers:	93.837, 93.838, 93.839
CFDA Descriptions:	Cardiovascular Diseases Research; Lung Diseases Research; Blood Diseases and Resources Research
Current Application Deadline:	Oct 21, 2016
Original Application Deadline:	Oct 21, 2016
Posted Date:	Jul 17, 2015
Creation Date:	Jul 17, 2015
Archive Date:	Nov 21, 2016
Total Program Funding:
Maximum Federal Grant Award:	$350,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Special district governments
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
State governments
Private institutions of higher education
Native American tribal governments (Federally recognized)
Small businesses
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public and State controlled institutions of higher education
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-16-003.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...; • The Relationship Between Hypertension and Inflammation; • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...; • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...